Prognosis related to staging systems for chronic lymphocytic leukemia.

10Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

CONTEXT: Chronic lymphocytic leukemia (CLL) is a clonal lymphoproliferative disorder, characterized by B lymphocytic proliferation. CLL is the most frequent adult leukemia in Western countries, accounting for 25 to 30% of all white leukemic patients. OBJECTIVE: To evaluate clinical and staging characteristics in prognosis of chronic lymphocytic leukemia. DESIGN: Evaluation of clinical-staging data. SETTING: Universidade Federal de São Paulo - Escola Paulista de Medicina / Universidade de Alfenas. SAMPLE: 73 patients diagnosed from 1977 to 1994. MAIN MEASUREMENTS: Sex, ethnic origin, age, lymphadenopathy, splenomegaly, hepatomegaly, three or more areas of lymphoid enlargement, hemoglobin (g/dl), lymphocytes/mm3, Platelets/mm3 RESULTS: Mean survival of patients was 76 months, median age was 65 years, ranging from 33 to 87. Forty-four patients (60.3%) were male and 29 (39.7%) female. CONCLUSION: The Binet system determined a better prognosis than Rai.

Cite

CITATION STYLE

APA

de Faria, J. R., de Oliveira, J. S., Delbone de Faria, R. M., Silva, M. R., Goihman, S., Yamamoto, M., & Kerbauy, J. (2000). Prognosis related to staging systems for chronic lymphocytic leukemia. São Paulo Medical Journal = Revista Paulista de Medicina, 118(4), 83–88. https://doi.org/10.1590/s1516-31802000000400002

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free